Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas

Metabolism: Clinical and Experimental

Volumn 45, Issue 2, 1996, Pages 184-189

  Fujitani, Shoji ^a   Ikenoue, Takao ^b   Akiyoshi, Megumi ^b   Maki, Toshio ^b   Yada, Toshihiko ^b  

^a POLA R and D Laboratories   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DIAZOXIDE; GLUCAGON; INSULIN; NATEGLINIDE; NITRENDIPINE; POTASSIUM CHANNEL; SOMATOSTATIN; TOLBUTAMIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DIABETES MELLITUS; DRUG INHIBITION; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HYPOGLYCEMIA; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0029886368     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90051-7     Document Type: Article

References (38)

1. Henquin JC: Established, unsuspected and novel pharmacological insulin secretagogues, in Bailey CJ, Flatt PR (eds): New Antidiabetic Drugs. London, UK, Smith-Gordon, 1990, pp. 93-106
2. Greco AV, Caputo S, Bertoli A, et al: The beta cell function in NIDDM patients with secondary failure. Horm Metab Res 24:280-283, 1992
3. Groop LC, Pelkonen R, Koskimies S, et al: Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care 9:129-133, 1986
4. Shinkai H, Toi K, Kumashiro I, et al: N-Acylphenylalanines and related compounds. A new class of oral hypoglycemic agents. J Med Chem 31:2092-2097, 1988
5. Shinkai H, Nishikawa M, Sato Y, et al: N-(cyclohexylcarbonyl)-D-Phenylalanines and related compounds. A new class of oral hypoglycemic agents. II. J Med Chem 32:1436-1441, 1989
6. Sato Y, Nishikawa M, Shinkai H, et al: Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals. Diabetes Res Clin Pract 12:53-60, 1991
7. Hirose H, Maruyama H, Itoh K, et al: Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas. Pharmacology 48:205-210, 1994
8. 2+ influx. Endocrinology 134: 1395-1400, 1994
9. Lefébvre PJ: Diabetes: Abnormal secretion of glucagon, in Samols E (ed): The Endocrine Pancreas. New York, NY, Raven, 1991, pp 191-205
10. Raskin P, Unger RH: Hyperglucagonemia and its suppression; importance in the metabolic control of diabetes. N Engl J Med 299:433-436, 1978
11. Unger RH, Orci L: Possible roles of the pancreatic D-cell in the normal and diabetic states. Diabetes 26:241-244, 1977
12. Oliver JR, Wagle SR: Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of Langerhans and isolated hepatocytes. Biochem Biophys Res Commun 62:772-777, 1975
13. Wahren J: Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 2:1213-1216, 1976
14. Samols E, Stagner JI: Islet somatostatin - Microvascular, paracrine, and pulsatile regulation. Metabolism 39:55-60, 1990 (suppl 2)
15. Gerich JE: Somatostatin: Its possible role in carbohydrate homeostasis and the treatment of diabetes mellitus. Arch Intern Med 137:659-666, 1977
16. Maugh TH: Diabetes. III. New hormones promise more effective therapy. Science 188:922-923, 1975
17. Grodsky GM, Batts AA, Bennett LL, et al: Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Am J Physiol 205:638-644, 1963
18. 2+ channel activity. Endocrinology 133:1685-1692, 1993
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
20. Yada T, Sakurada M, Ihida K, et al: Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intrapancreatic regulator of insulin secretion from islet β-cells. J Biol Chem 269:1290-1293, 1994
21. Ashcroft FM, Kelly RP, Smith PA: Two types of Ca channel in rat pancreatic β-cells. Pflugers Arch 415:504-506, 1990
22. Penner R, Neher E: The role of calcium in stimulus-secretion coupling in excitable and non-excitable cells. J Exp Biol 139:329-345, 1988
23. Ammälä C, Eliasson L, Bokvist K, et al: Exocytosis elicited by action potentials and voltage-clamp calcium currents in individual mouse pancreatic B-cells. J Physiol 472:665-688, 1993
24. Ashcroft FM, Rorsman P: Electrophysiology of the pancreatic β-cell. Prog Biophys Mol Biol 54:87-143, 1989
25. + channel in mouse pancreatic β-cells. Pflugers Arch 407:493-499, 1986
26. Beckh K, Ehlenz K, Arnold R: Modulation by somatostatin of nerve-mediated activation of glycogenolysis in the perfused rat liver. FEBS Lett 250:345-348, 1989
27. Klaff LJ, Dunning BE, Taborsky GJ: Somatostatin-28 does not regulate islet function in the dog. Endocrinology 123:2668-2674, 1988
28. Schuit FC, Derde MP, Pipeleers DG: Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 32:207-212, 1989
29. Panten U, Schwanstecher M, Schwanstecher C: Pancreatic and extrapancreatic sulfonylurea receptors. Horm Metab Res 24:549-554, 1992
30. Ronner P, Cheong E, Khalid P, et al: Effect of linogliride on hormone release from perfused rat pancreas. Fuel dependence and desensitization by tolbutamide. Diabetes 40:878-884, 1991
31. + channels in pancreatic β-cells by the nonsulfonylurea drug linogliride. Diabetes 40:885-892, 1991
32. Garrino MG, Schmeer W, Nenquin M, et al: Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulfonylurea moiety of glibenclamide. Diabetologia 28:697-703, 1986
33. Garrino MG, Meissner HP, Henquin JC: The non-sulfonylurea moiety of gliquidone mimics the effects of the parent molecule on pancreatic B-cells. Eur J Pharmacol 124:309-316, 1986
34. Ronner P, Hang TL, Kraebber MJ, et al: Effect of the hypoglycemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic β-cells. Br J Pharmacol 106:250-255, 1992
35. Efendic S, Grill V, Nylén A, et al: Difference in calcium dependency of insulin, glucagon and somatostatin secretion in response to glibenclamide in perfused rat pancreas. Diabetologia 22:475-479, 1982
36. Östenson CG, Nylen A, Grill V, et al: Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: Evidence for a direct, non-paracrine effect. Diabetologia 29:861-867, 1986
37. + channels in the release mechanism. Endocrinology 106:1843-1847, 1980
38. Ørskov C: Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35:701-711, 1992